8-K: Revelation Biosciences Adjusts Exercise Price of Class C and D Warrants

Revelation Biosciences has adjusted the exercise price of its Class C and D warrants, requiring a temporary manual exercise process until the Depository Trust Corporation system is updated.

Summary

• Revelation Biosciences has adjusted the exercise price of its Class C and D warrants.
• Class C warrants are now exercisable for 1/30th of a share at $2.39 per share.
• Class D warrants are now exercisable for one share at $2.39 per share.
• Due to system updates, the warrants cannot be exercised through the Depository Trust Corporation (DTC) system.
• Until the DTC system is updated, warrant holders must manually exercise their warrants by submitting a Notice of Warrant Exercise to the Warrant Agent.
• The Warrant Agent will provide wire transfer instructions and obtain DWAC instructions for settlement.
• All other terms and conditions of the warrants remain in effect.

Sentiment

Score: 6

Explanation: The document is neutral in tone, detailing a necessary adjustment to warrant terms. While there is a temporary inconvenience, the company has provided clear instructions for warrant holders.

Positives

• The adjustment of the exercise price may make the warrants more attractive to holders.
• The company has provided clear instructions for manual warrant exercise during the system update period.

Negatives

• The need for a manual exercise process may be inconvenient for warrant holders.
• The delay in updating the DTC system could cause a temporary disruption in warrant trading.

Risks

• The manual exercise process could lead to errors or delays in warrant execution.
• The delay in updating the DTC system could negatively impact warrant holder confidence.

Future Outlook

The company expects to resume normal warrant exercise procedures through the DTC system once the necessary updates are completed.

Industry Context

This announcement is specific to Revelation Biosciences and its warrant holders, and does not reflect broader industry trends.

Comparison to Industry Standards

• Warrant adjustments are a common occurrence in corporate finance, often triggered by events such as stock splits or dividends.
• The temporary manual exercise process is not standard, but is a necessary measure to ensure warrant holders can exercise their rights during the system update period.
• Other companies with similar warrant structures may face similar challenges when adjusting warrant terms.

Stakeholder Impact

• Warrant holders are directly impacted by the change in exercise price and the temporary manual exercise process.
• Shareholders may be indirectly impacted by the change in warrant terms.

Next Steps

• The company will update the Depository Trust Corporation (DTC) system to reflect the new warrant exercise prices.
• Warrant holders will continue to use the manual exercise process until the DTC system is updated.

Key Dates

Keywords

Warrants, Exercise Price, Revelation Biosciences, Class C Warrants, Class D Warrants, Depository Trust Corporation, DTC, Warrant Agent, Manual Exercise, DWAC